Portland, OR -- (SBWIRE) -- 08/10/2017 -- Peripheral intervention procedures are minimal invasive surgeries performed to remove plaques, which is a root cause of several diseases related to peripheral artery. Peripheral intervention surgeries are performed to restore the blood flow of the arteries. They are also used to remove clotting that prevents the flow of oxygenated blood. The increasing aging population and rising prevalence of heart diseases are augmenting the growth of peripheral intervention market in Asia-Pacific region. Moreover, technological innovations, shifting healthcare dynamics and growing clinical experiences are further driving the growth of peripheral intervention market in this region. Increasing number of patients with heart-related problems in India, China and Japan resulting in rising demand for peripheral intervention procedures. Thus, the peripheral intervention market would show remarkable growth during the forecast period.

Get a Sample Copy of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/1231

The Asia-Pacific peripheral intervention market is segmented on the basis of device type, application and geography. Based on devices type, the market is segmented into stents, balloons, PTCA devices and others. Based on application, the Asia-Pacific intervention procedures market is categorized into vascular procedures, oncology procedures, neurology procedures, skin procedures and others (hepatic, renal and uteral). The Asia-Pacific peripheral intervention market is segmented geographically into China, Japan, India, Australia, Singapore, Malaysia and others. Emerging economies such as India, China, Singapore and Malaysia are the potential geographies for market expansion due to improving healthcare standards. These economies have a large presence of domestic manufacturers, which contribute to an increase in the market competition. New product launches, R&D and collaborations are the key strategies adopted by the crucial players of this market. The companies profiled in this market include: Abbott Laboratories, AngioDynamics Inc., C.R. Bard Inc., Boston Scientific Corporation, Medtronic Inc., Cordis Corporation, Terumo Corporation, Braun Melsungen AG and few others.

PERIPHERAL INTERVENTION MARKET KEY SEGMENTS

The Asia-Pacific peripheral intervention market is segmented into three categories on the basis of device type, application and geography.

BY DEVICES TYPE

Stents
Drug eluting stents
Bio-absorbable stents
Balloon inflation devices
Bare metal stents
Balloons
Normal balloons
Drug eluting balloons
Cutting balloons
Scoring balloons
PTCA devices
Percutaneous Transluminal Coronary Angioplasty (PTCA) guidewires
Percutaneous Transluminal Coronary Angioplasty (PTCA) balloons
Percutaneous Transluminal Coronary Angioplasty (PTCA) guiding catheters
Others
Angiography catheters
Intravascular Ultrasound (IVUS)

BY APPLICATION

Vascular procedures
Oncology procedures
Neurology procedures
Skin procedures
Others
Hepatic
Renal
Uteral
Gastric

MARKET BY GEOGRAPHY

Asia-Pacific
India
China
Japan
Singapore
Malaysia
Others